Acute myeloid leukemia (AML) is a clonal hematopoietic disorder characterized by the malignant transformation and abnormal proliferation of bone marrow-derived, self-renewing stem cells, or CD34+ CD38− myeloid progenitors [1,2,3]. The gene discussed is CD38; the disease is acute myeloid leukemia.